Dr. Reddy's Laboratories Files Routine 6-K Report

Ticker: RDY · Form: 6-K · Filed: Oct 4, 2024 · CIK: 1135951

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

DRL filed a 6-K, just routine paperwork, no big news.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 4, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events beyond its routine reporting nature.

Why It Matters

This filing indicates Dr. Reddy's is fulfilling its ongoing disclosure obligations as a foreign private issuer with the SEC, which is standard practice for companies with publicly traded securities in the US.

Risk Assessment

Risk Level: low — This filing is a standard procedural report for a foreign private issuer and does not contain new material information that would typically impact risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have submitted or are required to submit to a stock exchange on which they are listed.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is October 4, 2024.

Is Dr. Reddy's Laboratories Ltd. required to file Form 20-F?

Yes, the filing indicates that Dr. Reddy's Laboratories Ltd. files annual reports under cover of Form 20-F.

What is the principal executive office address for Dr. Reddy's Laboratories Ltd.?

The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Does this filing contain specific financial results or material events?

Based on the provided text, this Form 6-K appears to be a routine filing and does not detail specific financial results or new material events.

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-10-04 15:16:18

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: October 4, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing